Epitalon
Compoundable (Rx)Anti-Aging Peptides · Telomere Support
Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on epithalamin, a peptide produced by the pineal gland.
What is Epitalon?
Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on epithalamin, a peptide produced by the pineal gland. It is one of the most studied anti-aging peptides, primarily investigated for its ability to activate telomerase and potentially extend cellular lifespan. Developed by Professor Vladimir Khavinson in Russia.
Also known as: Epithalon, Epithalamin, AGAG peptide
How Does Epitalon Work?
Activates telomerase, the enzyme responsible for maintaining and elongating telomeres — the protective caps on chromosomes that shorten with age. Also stimulates melatonin production by the pineal gland and modulates the neuroendocrine system.
What is Epitalon Used For?
- Anti-aging
- Telomere maintenance
- Sleep regulation
- Cellular longevity
Potential Side Effects
- Injection site irritation
- Drowsiness
- Headache (rare)
Contraindications
- Pregnancy
- Active cancer (telomerase activation concern)
FDA Legal Status
United States — FDA
Compoundable (Rx)Category 1 (restored 2026)
Related Peptides
GHK-Cu
Compoundable (Rx)Anti-Aging Peptides
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex found in human pla...
MOTS-c
Compoundable (Rx)Metabolic Peptides
MOTS-c is a mitochondrial-derived peptide encoded within the 12S rRNA gene. It functions as an exercise mimetic, activat...
Head-to-head comparisons:
Frequently Asked Questions
Does epitalon really extend lifespan?
Should you worry about cancer with epitalon?
Quick Facts
- Legal Status (USA)
- Compoundable (Rx)
- FDA Category
- Category 1 (restored 2026)
- Evidence Rating
- CPreliminary Evidence (Mostly Preclinical)
- Class / Subclass
- Anti-Aging Peptides / Telomere Support
- Administration
- subcutaneous, intravenous
- Typical Dosage
- 5-10mg daily for 10-20 day cycles
- Half-Life
- ~2-3 hours
- Year Discovered
- 2003
Sources
Last updated: 2026-04-01
Sources & references
Primary sources used for the dosing, mechanism, side-effect, and regulatory claims on this page. Verify time-sensitive information (regulatory status, prescribing details) on the source before relying on it for medical decisions. See our disclaimer.
- PubMed PMID 12937682 — peer-reviewed primary literature on Epitalon.
- FDA Federal Register — official notice record for FDA regulatory actions and Category 1 / 503A bulk-substance updates.